Amplifica Completes $11.8 Million Series A Financing to Enable Clinical Development of Lead Products to Treat Androgenic Alopecia

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Amplifica Holdings Group, Inc. ('Amplifica'), a privately-held, clinical-stage biopharmaceutical company ...

Related Keywords

United States ,California ,Irvine ,Frank Fazio ,University Of California ,Prnewswire Amplifica Holdings Group Inc ,Amplifica Holdings Group Inc ,Aegis Capital Corporation ,National Institutes Of Health ,Holdings Group ,Preferred Stock ,National Institutes ,Maksim Plikus Phd ,Chief Scientific Officer ,Cell Biology ,Sternaegis Ventures ,Aegis Capital ,About Amplifica Holdings Group ,